美东时间周二早间，赛诺菲（SNY）股价上涨逾1%，此前该公司宣布以16亿美元收购Vicebio以强化其呼吸系统产品管线。

　　该交易包括11.5亿美元首付款及4.5亿美元里程碑款项。

　　通过此次收购，赛诺菲将获得Vicebio分子钳技术平台，该技术对开发新一代疫苗具有关键作用。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张俊 SF065

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.